Abboud Bassam, Daher Ronald, Boujaoude Joe
World J Gastroenterol. 2008 Sep 21;14(35):5361-70. doi: 10.3748/wjg.14.5361.
Acute mesenteric ischemia (AMI) is a highly-lethal surgical emergency. Several pathophysiologic events (arterial obstruction, venous thrombosis and diffuse vasospasm) lead to a sudden decrease in mesenteric blood flow. Ischemia/reperfusion syndrome of the intestine is responsible for systemic abnormalities, leading to multi-organ failure and death. Early diagnosis is difficult because the clinical presentation is subtle, and the biological and radiological diagnostic tools lack sensitivity and specificity. Therapeutic options vary from conservative resuscitation, medical treatment, endovascular techniques and surgical resection and revascularization. A high index of suspicion is required for diagnosis, and prompt treatment is the only hope of reducing the mortality rate. Studies are in progress to provide more accurate diagnostic tools for early diagnosis. AMI can complicate the post-operative course of patients following cardio-pulmonary bypass (CPB). Several factors contribute to the systemic hypo-perfusion state, which is the most frequent pathophysiologic event. In this particular setting, the clinical presentation of AMI can be misleading, while the laboratory and radiological diagnostic tests often produce inconclusive results. The management strategies are controversial, but early treatment is critical for saving lives. Based on the experience of our team, we consider prompt exploratory laparotomy, irrespective of the results of the diagnostic tests, is the only way to provide objective assessment and adequate treatment, leading to dramatic reduction in the mortality rate.
急性肠系膜缺血(AMI)是一种致死率很高的外科急症。多种病理生理事件(动脉阻塞、静脉血栓形成和弥漫性血管痉挛)导致肠系膜血流突然减少。肠道缺血/再灌注综合征会引发全身异常,进而导致多器官功能衰竭和死亡。早期诊断困难,因为临床表现不明显,而且生物学和放射学诊断工具缺乏敏感性和特异性。治疗选择包括保守复苏、药物治疗、血管内技术以及手术切除和血管重建。诊断需要高度的怀疑指数,及时治疗是降低死亡率的唯一希望。目前正在进行相关研究以提供更准确的早期诊断工具。AMI会使体外循环(CPB)术后患者的病程复杂化。多种因素导致全身灌注不足状态,这是最常见的病理生理事件。在这种特殊情况下,AMI的临床表现可能会产生误导,而实验室和放射学诊断测试往往结果不明确。管理策略存在争议,但早期治疗对挽救生命至关重要。根据我们团队的经验,我们认为无论诊断测试结果如何,迅速进行剖腹探查是提供客观评估和充分治疗的唯一方法,可显著降低死亡率。